Knight Therapeutics Inc Annual Shareholders Meeting Transcript
Hello, and welcome to the Annual Meeting of Stockholders of Knight Therapeutics. Please note, today's meeting is being recorded. (Operator Instructions)
It is now my pleasure to turn the meeting over to Jonathan Goodman, CEO of Knight Therapeutics. The floor is yours.
Good morning. Welcome to Knight Therapeutics' Annual Meeting of Shareholders. We have chosen to hold the meeting via live audio webcast rather than in person as a result of the recent global pandemic due to COVID-19 and to ensure everyone's safety.
My name is Jonathan Goodman, CEO of Knight Therapeutics. And exceptionally, I will chair today's meeting. Also with me on this call is Samira Sakhia, our President; and Bryan Kujawski, our External Counsel. Samira will act as secretary of today's meeting. Bertrand Gely and [Ivan Karekezi] of AST Trust Company will be acting as scrutineers for this meeting.
Our agenda today is straightforward. First, we will conduct the formal part of the meeting.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |